Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
about
Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.Glutathione and drug resistance.Copper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo.In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II).Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivo.Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy.Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin.Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance.A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies.
P2860
Q33822719-C0FE9EB5-89D2-4732-BFB0-CAF7CC6CBEF6Q34374824-E9093F5E-3CA4-489A-B632-53FDB079A27BQ34458507-4185B87D-A4EB-4341-95DC-807CA8BBA7CBQ35977240-599DEC6B-437D-426E-9D16-7BCCBE4CA916Q35994616-A7099B4C-2FDD-494A-8CCA-92CCE3494018Q36135855-AB213AD4-0C54-4AB2-AEF1-A338053A7B35Q36695785-44F41B73-E68D-4B7F-B32A-525166D90209Q36841450-74DAA6DA-8DB9-45EF-B0EA-CAC3BFB06A22Q40860946-4E313111-FC5E-4E90-91C9-14AF700441A0Q41202524-F6C21D24-A5E2-490B-8D36-EBD30B55DCD4Q43558328-0699EAA9-B0A4-46E0-A092-7B808820C26FQ47921996-D257D557-7A0C-4117-BB6F-87D6C76EC250Q52935006-DFE8BE57-F411-426B-9D61-1AF7080F2CA5
P2860
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Characteristics of five human ...... o cis-diamminedichloroplatinum
@nl
Characteristics of five human ...... -diamminedichloroplatinum(II).
@en
type
label
Characteristics of five human ...... o cis-diamminedichloroplatinum
@nl
Characteristics of five human ...... -diamminedichloroplatinum(II).
@en
prefLabel
Characteristics of five human ...... o cis-diamminedichloroplatinum
@nl
Characteristics of five human ...... -diamminedichloroplatinum(II).
@en
P2093
P2860
P356
P1476
Characteristics of five human ...... -diamminedichloroplatinum(II).
@en
P2093
B A Teicher
E A Sotomayor
S A Holden
T S Herman
T T Korbut
V Khandekar
P2860
P304
P356
10.1002/IJC.2910470214
P577
1991-01-01T00:00:00Z